---
schema_version: "secwatch.filing_event.v1"
accession: "0001815776-26-000041"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2026-06-12T20:08:05+00:00"
generated_at: "2026-06-12T20:21:08.333010+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# LENZ Therapeutics shareholders elect three Class II directors and ratify auditor at 2026 annual meeting.

## Summary
- Votes for Evert Schimmelpennink: 20,216,637; withheld: 230,219; broker non-votes: 3,995,212.
- Votes for Jeff George: 13,462,359; withheld: 6,984,497; broker non-votes: 3,995,212.
- Votes for Shelley Thunen: 20,215,686; withheld: 231,170; broker non-votes: 3,995,212.
- Ratification of Ernst & Young as auditor passed: 24,310,915 for, 55,181 against, 75,972 abstain.

## SEC filing metadata
- accession: 0001815776-26-000041
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2026-06-12T20:08:05+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/lenz-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001815776-26-000041
- JSON: https://secwatch.observer/filing/0001815776-26-000041.json
- Plain text: https://secwatch.observer/filing/0001815776-26-000041.txt

## Key facts
- Shareholder Votes
  LENZ Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Votes For Votes Against Abstentions Broker Non-Votes 24,310,915 55,181 75,972 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm
- Shareholder Votes
  LENZ Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2026-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Nominee Votes For Votes Withheld Broker Non-Votes Evert Schimmelpennink 20,216,637 230,219 3,995,212 Jeff George 13,462,359 6,984,497 3,995,212 Shelley Thunen 20,215,686 231,170 3,995,212
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.